What services does JCC Group provide for pharmaceutical and biologics manufacturers?

JCC Group offers end-to-end regulatory consulting services for pharmaceutical and biologics companies, including 21 CFR Part 211 cGMP compliance, Quality Management System (QMS) design, validation strategy, FDA inspection readiness, supplier qualification, data integrity assessments, and harmonization with ICH international standards (Q7, Q8, Q9, Q10, and Q11). Our consultants partner with clients across the full product lifecycle — from facility start-up and clinical-stage manufacturing through commercial production and post-approval changes.

What types of companies does JCC Group work with?

We support a broad spectrum of clients, including emerging biotech startups, contract manufacturers (CMOs/CDMOs), mid-size pharmaceutical companies, global drug manufacturers, biologics and cell & gene therapy developers, and international manufacturers exporting to the U.S. market. Whether you are launching your first product or managing a multi-site global operation, our services scale to fit your needs.

What is 21 CFR Part 211, and who must comply?

21 CFR Part 211 establishes the FDA's Current Good Manufacturing Practice (cGMP) requirements for finished pharmaceuticals. It applies to any company involved in manufacturing, processing, packaging, labeling, or holding human and veterinary drug products distributed in the United States — including drug substance and drug product manufacturers, contract facilities, and repackagers.

How does JCC Group help companies achieve 21 CFR Part 211 compliance?

We provide comprehensive support including cGMP gap assessments, QMS design and implementation, SOP and documentation development, equipment qualification (IQ/OQ/PQ), process and cleaning validation, quality control laboratory compliance, change control programs, CAPA systems, and mock FDA inspections. Our team builds compliance programs tailored to your operations — not generic templates.

Does JCC Group support biologics manufacturers under 21 CFR Part 211?

Yes. While biologics are also governed by 21 CFR Part 600-series regulations, Part 211 still applies to many aspects of biologic drug product manufacturing. We support biologics manufacturers across monoclonal antibodies, recombinant proteins, vaccines, cell and gene therapies, and biosimilars — addressing both small-molecule and large-molecule complexities.

What are ICH guidelines, and why do they matter?

The International Council for Harmonisation (ICH) develops globally recognized standards for pharmaceutical quality, safety, and efficacy. Compliance with ICH guidelines — especially Q7 (API GMP), Q8 (Pharmaceutical Development), Q9 (Quality Risk Management), Q10 (Pharmaceutical Quality System), and Q11 (Drug Substance Development) — is essential for companies seeking global market access and harmonized regulatory approval across the U.S., EU, Japan, and other ICH regions.

How does JCC Group help companies align with ICH standards?

Our consultants integrate ICH principles into every aspect of our consulting work. We design Pharmaceutical Quality Systems aligned with ICH Q10, implement quality risk management frameworks per ICH Q9, support development activities under Q8/Q11, and ensure API manufacturing aligns with ICH Q7 — enabling clients to meet both FDA expectations and global harmonized requirements simultaneously.

Can JCC Group build a Quality Management System (QMS) from scratch?

Absolutely. We design and implement complete Quality Management Systems for new facilities, startups, and companies transitioning from clinical-stage to commercial manufacturing. Our QMS deliverables include Quality Manuals, SOPs, work instructions, forms, Master Production Records, Batch Production Records, change control systems, and integrated documentation control platforms.

Does JCC Group provide ongoing QMS maintenance and support?

Yes. Beyond initial implementation, we offer long-term advisory services to keep your QMS current with evolving regulations, support periodic management reviews, conduct internal audits, manage CAPA effectiveness checks, and provide regulatory intelligence updates. Many clients engage us as their long-term regulatory partner rather than a one-time consultant.

What happens during a mock FDA inspection conducted by JCC Group?

Our mock inspections replicate real FDA methodology — including facility walkthroughs, document reviews, employee interviews, and front-room/back-room dynamics. We assess your operations against 21 CFR Part 211, your QMS, and applicable ICH standards, then deliver a detailed report with prioritized findings, root cause insights, and clear remediation recommendations.

Can JCC Group help if we received a Form 483 or FDA Warning Letter?

Yes — rapid-response remediation is one of our core specialties. Our team conducts immediate root cause investigations, develops comprehensive CAPA plans, drafts written responses that meet FDA expectations, and manages the remediation process from start to finish. We have helped clients successfully close significant findings and restore compliance under tight deadlines.

FDA Regulatory Services for Dietary Supplements

Q: What's the difference between Part 111 and Part 117?

Part 111 is specific to finished dietary supplements, while Part 117 applies to conventional human food and food ingredients. Many companies are subject to both regulations — for example, a facility that manufactures both supplement capsules and functional food powders must comply with each respective standard.

Providing regulatory guidance and quality assurance to ensure dietary ingredients meet safety standards and global market requirements successfully.

Call for Appoinment

800 999 7781

99%

Satisfy client

Years of Experience

0 +

Assurance

Comprehensive Regulatory Services for Dietary Supplements& Nutraceuticals

JCC Group delivers end-to-end regulatory compliance solutions tailored to dietary supplement and nutraceutical brands navigating today’s complex FDA landscape. Our experienced consultants partner with you at every stage of the product lifecycle, ensuring your formulations, labels, and operations align with current federal regulations and industry best practices.

From new product development and ingredient review to FDA labeling compliance, GMP manufacturing oversight, and structure/function claim substantiation, we provide the strategic guidance brands need to launch confidently and stay compliant. We also support international market entry, helping you expand globally while meeting the regulatory requirements of target regions efficiently and cost-effectively.

Whether you’re an emerging supplement startup or an established nutraceutical company scaling new product lines, JCC Group is your trusted regulatory partner — combining deep FDA expertise with a practical, business-focused approach that keeps your products moving from concept to consumer.

Our Expertise Covers

Expert Regulatory Consulting Tailored to Your Needs

We offer a comprehensive suite of regulatory services designed to navigate the complex and ever-evolving compliance landscape, from initial strategy development and submission preparation to post-approval lifecycle management. Whether you’re a startup launching your first product or an established organization expanding into new territories, our experts deliver the deep technical knowledge and strategic insight needed to move your projects forward with confidence.

Labeling Review & Compliance

01/

New Product Development Support

02/

Good Manufacturing Practices (CGMP)

03/

21 CFR 111 Compliance
Process Validation and Control
Supplier Selection and Qualification
Corrective and Preventive Action Program (CAPA)
Management Review Meetings
Facility and Equipment Compliance Readness

Comprehensive International Market Entry

04/

FDA Regulation for dietary Supplement
Health Canada (NNHPD) licensing
EU/EFSA claims and notification
APAC compliance (TGA, KFDA, etc.)
Latin American regulatory approvals
Middle East and African compliance

Dietary supplement brands
Nutraceutical companies
Functional food manufacturers
Contract manufacturers
Amazon and eCommerce sellers
Health & wellness startups

Who we work with

Trusted by Industry Leaders Across Supplements

Years Of Research

0 +

Satisfaction Rate

0 %

Medical Partner

0 +

Our Advantages

Why choose J&JCC Group for dietary supplement compliance

JJCC Group provides industry-specific regulatory consulting for dietary supplements and nutraceuticals. We deliver tailored compliance strategies, hands-on implementation, and trusted guidance to help brands succeed.

Industry-specific expertise

We specialize exclusively in supplements and nutraceuticals, providing in-depth regulatory knowledge and industry-focused compliance strategies.

Personalized compliance roadmaps

Every company is unique; we create compliance plans tailored to products, risk levels, and distribution channels.

Regulatory intelligence + execution

Our experts combine knowledge of FDA regulations with practical experience to implement effective compliance solutions.

Trusted by industry leaders

We help emerging and established brands achieve market leadership through regulatory guidance and audit readiness.

New Product Launch Support

JJCC Group helps manufacturers and brand names companies in ingredient assessment, GRAS classification and NDI submissions, health claim and readiness checks for market.

Manufacturing & Quality Compliance

We perform cGMP quality audits, create QMS, and provide employee training to ensure consistent compliance to regulation 21 CFR 111, 21 CFR 117, and 21CFR 101.

Global Market Expansion Guidance

We provide expert guidance for Health Canada, EU/EFSA, APAC compliance, including TGA, KFDA, and other international regulations.

How We Help Your Dietary Supplements Achieve Complete Regulatory Compliance

Regulatory Consulting Services

Comprehensive Regulatory Services for Dietary Supplement

JCC Group provides end-to-end regulatory compliance support for dietary supplements and nutraceuticals. We help brands meet FDA regulations, ensure labeling accuracy, manage manufacturing compliance, guide new product development, and support international market entry efficiently.

Best Compliance with 5 Star

99% Happy Clients

Testimonial

What our clients say about JJCC

Leading supplement and nutraceutical companies trust JJCC for reliable regulatory guidance and successful product approvals.

JJCC expertly managed our dietary supplement compliance, ensuring FDA approval, labeling, GMP, and regulatory requirements smoothly.

Leann Chen Manager

Their team expertly guided our dietary supplement labeling, NDIN notifications, GMP audits, and overall regulatory compliance efficiently and effectively.

Dr. Michelle Director

JJCC provided expert guidance on dietary supplement compliance, GMP, NDIN submissions, labeling, and international regulatory requirements.

Kyle Shahen CEO

Faqs

Frequently asked questions

JJCC Group provides clear guidance on dietary supplement compliance, FDA regulations, labeling, manufacturing, and international market requirements.

Our experts assist with ingredient assessments, GRAS and NDI notifications, claim substantiation, GMP audits, SOP development, and global market entry strategies.

What is 21 CFR Part 111?

21 CFR Part 111 establishes the FDA’s Current Good Manufacturing Practice (cGMP) regulations specifically for dietary supplements. It governs the manufacturing, packaging, labeling, and holding operations of dietary supplement products, ensuring they meet identity, purity, strength, and composition standards

What is 21 CFR Part 117?

21 CFR Part 117 outlines the cGMP, Hazard Analysis, and Risk-Based Preventive Controls for Human Food under the FDA Food Safety Modernization Act (FSMA). It applies to facilities that manufacture, process, pack, or hold human food — including many nutraceutical ingredients and functional food products — and requires a written Food Safety Plan, hazard analysis, and a Preventive Controls Qualified Individual (PCQI) on staff.

What's the difference between Part 111 and Part 117?

Part 111 is specific to finished dietary supplements, while Part 117 applies to conventional human food and food ingredients. Many companies are subject to both regulations — for example, a facility that manufactures both supplement capsules and functional food powders must comply with each respective standard.

Who needs to comply with these regulations

Any company involved in manufacturing, packaging, labeling, holding, or distributing dietary supplements (Part 111) or human food and ingredients (Part 117) within the U.S. market must comply — including contract manufacturers, private label brands, importers, and ingredient suppliers.

What are the consequences of non-compliance?

Non-compliance can result in FDA Warning Letters, Form 483 observations, product recalls, import detentions, injunctions, and even criminal penalties in severe cases. Beyond regulatory risk, non-compliance damages brand reputation, retailer relationships, and consumer trust.